How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?

References

• de Vries AAF, Horzinek MC, Rottier PJM, de Groot RJ. The genome organization of the nidovirales: similarities and differences between arteri-, toro-, and coronaviruses. Semin Virol. 1997;8(1):33–47. doi:10.1006/smvy.1997.0104.
   PubMedGoogle Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7.
   PubMed Web of Science ®Google Scholar
• Zhou H, Chen X, Hu T, et al. A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein. Curr Biol. 2020;30(11):2196–2203.e3. doi:10.1016/j.cub.2020.05.023.
   PubMed Web of Science ®Google Scholar
• Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–224. doi:10.1038/s41586-020-2179-y.
   PubMed Web of Science ®Google Scholar
• Benton DJ, Wrobel AG, Xu P, et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature. 2020. doi:10.1038/s41586-020-2772-0
   Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020;78(4):779–784.e5. doi:10.1016/j.molcel.2020.04.022.
   PubMed Web of Science ®Google Scholar
• Zhou J, Li C, Liu X, et al. Infection of bat and human intestinal organoids by SARS-CoV-2. Nat Med. 2020;26(7):1077–1083. doi:10.1038/s41591-020-0912-6.
   PubMed Web of Science ®Google Scholar
• Wang X, Zheng J, Guo L, et al. Fecal viral shedding in COVID-19 patients: clinical significance, viral load dynamics and survival analysis. Virus Res. 2020;289:198147. doi:10.1016/j.virusres.2020.198147.
   PubMed Web of Science ®Google Scholar
• Kumar V. Understanding the complexities of SARS-CoV2 infection and its immunology: a road to immune-based therapeutics. Int Immunopharmacol. 2020;88:106980. doi:10.1016/j.intimp.2020.106980.
   PubMed Web of Science ®Google Scholar
• Oude Munnink BB, Sikkema RS, Nieuwenhuijse DF, et al. Jumping back and forth: anthropozoonotic and zoonotic transmission of SARS-CoV-2 on mink farms. bioRxiv 2020.09.01.277152, 2020.
   Google Scholar
• Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Antiviral activities of type I interferons to SARS-CoV-2 infection. Antiviral Res. 2020;179:104811. doi:10.1016/j.antiviral.2020.104811.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570. doi:10.1126/science.abd4570.
   PubMed Web of Science ®Google Scholar
• Bastard P, Rosen LB, Zhang Q, et al. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4585. doi:10.1126/science.abd4585.
   PubMed Web of Science ®Google Scholar
• Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016–1035.e19. doi:10.1016/j.cell.2020.04.035.
   PubMed Web of Science ®Google Scholar
• Bestle D, Heindl MR, Limburg H, et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance. 2020;3(9):e202000786. doi:10.26508/lsa.202000786.
   PubMed Web of Science ®Google Scholar
• Kumar V. Emerging human coronavirus infections (SARS, MERS, and COVID-19): where they are leading us. Int. Rev. Immunol. 2020;1–49. doi:10.1080/08830185.2020.1800688.
   Web of Science ®Google Scholar
• Kumar V. Inflammation research sails through the sea of immunology to reach immunometabolism. Int Immunopharmacol. 2019;73:128–145. doi:10.1016/j.intimp.2019.05.002.
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–565. doi:10.1038/nri.2016.70.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38(4):633–643. doi:10.1016/j.immuni.2013.04.005.
   PubMed Web of Science ®Google Scholar
• Man K, Kutyavin VI, Chawla A. Tissue immunometabolism: development, physiology, and pathobiology. Cell Metab. 2017;25(1):11–26. doi:10.1016/j.cmet.2016.08.016.
   PubMed Web of Science ®Google Scholar
• Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068–1077.e3. doi:10.1016/j.cmet.2020.04.021.
   PubMed Web of Science ®Google Scholar
• Zhang J, Kong W, Xia P, et al. Impaired fasting glucose and diabetes are related to higher risks of complications and mortality among patients with coronavirus disease 2019. Front Endocrinol. 2020;11:525. doi:10.3389/fendo.2020.00525.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cui Y, Shen M, et al. Association of diabetes mellitus with disease severity and prognosis in COVID-19: a retrospective cohort study. Diabetes Res Clin Pract. 2020;165:108227. doi:10.1016/j.diabres.2020.108227.
   PubMed Web of Science ®Google Scholar
• Long Q-X, Tang X-J, Shi Q-L, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200–1204. doi:10.1038/s41591-020-0965-6.
   PubMed Web of Science ®Google Scholar
• Ma Y, Xu Q-n, Wang F-l, et al. Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China. Microbes Infect. 2020;22(4-5):212–217. doi:10.1016/j.micinf.2020.04.011.
   PubMed Web of Science ®Google Scholar
• Thevarajan I, Nguyen THO, Koutsakos M, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020;26(4):453–455. doi:10.1038/s41591-020-0819-2.
   PubMed Web of Science ®Google Scholar
• Helmold Hait S, Vargas-Inchaustegui DA, Musich T, et al. Early T follicular helper cell responses and germinal center reactions are associated with viremia control in immunized rhesus macaques. J Virol. 2018;93(4):e01687-18. doi:10.1128/JVI.01687-18.
   Web of Science ®Google Scholar
• Wilk AJ, Rustagi A, Zhao NQ, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med. 2020;26(7):1070–1076. doi:10.1038/s41591-020-0944-y.
   PubMed Web of Science ®Google Scholar
• Bost P, Giladi A, Liu Y, et al. Host-viral infection maps reveal signatures of severe COVID-19 patients. Cell. 2020;181(7):1475–1488.e12. doi:10.1016/j.cell.2020.05.006.
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Schmitz KS, Raadsen MP, et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020;5(48):eabd2071. doi:10.1126/sciimmunol.abd2071.
   PubMed Web of Science ®Google Scholar
• Edridge AWD, Kaczorowska J, Hoste ACR, et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020. doi:10.1038/s41591-020-1083-1.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Kitahata K, Kawabata F, et al. A highly active form of XCL1/lymphotactin functions as an effective adjuvant to recruit cross-presenting dendritic cells for induction of effector and memory CD8+ T cells. Front Immunol. 2018;9:2775. doi:10.3389/fimmu.2018.02775.
   PubMed Web of Science ®Google Scholar
• Mackay LK, Rahimpour A, Ma JZ, et al. The developmental pathway for CD103 + CD8+ tissue-resident memory T cells of skin. Nat Immunol. 2013;14(12):1294–1301. doi:10.1038/ni.2744.
   PubMed Web of Science ®Google Scholar
• Behr FM, Parga-Vidal L, Kragten NAM, et al. Tissue-resident memory CD8+ T cells shape local and systemic secondary T cell responses. Nat Immunol. 2020;21(9):1070–1081. doi:10.1038/s41590-020-0723-4.
   PubMed Web of Science ®Google Scholar
• Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181(7):1489–1501.e15. doi:10.1016/j.cell.2020.05.015.
   PubMed Web of Science ®Google Scholar
• Ni L, Ye F, Cheng M-L, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52(6):971–977.e3. doi:10.1016/j.immuni.2020.04.023.
   PubMed Web of Science ®Google Scholar
• Kusnadi A, Ramírez-Suástegui C, Fajardo V, et al. Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8 (+) T cells. bioRxiv. 2020.
   Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunologic features in severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi:10.1172/JCI137244.
   PubMed Web of Science ®Google Scholar
• Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020.
   PubMed Web of Science ®Google Scholar
• Schultheiß C, Paschold L, Simnica D, et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. 2020;53(2):442–455.e4.
   PubMed Web of Science ®Google Scholar
• Mazzoni A, Salvati L, Maggi L, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130(9):4694–4703.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708–712. doi:10.1038/44385.
   PubMed Web of Science ®Google Scholar
• Meckiff BJ, Ramírez-Suástegui C, Fajardo V, et al. Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4+ T cells. bioRxiv. 2020.06.12.148916. 2020.
   Google Scholar
• Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326–336. doi:10.1111/j.1365-3083.2009.02308.x.
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Iyoda T, Tarbell K, et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med. 2003;198(2):235–247. doi:10.1084/jem.20030422.
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Bonito AJ, Spisek R, Dhodapkar M, Inaba K, Steinman RM. Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors. Blood. 2007;110(13):4293–4302. doi:10.1182/blood-2007-05-088831.
   PubMed Web of Science ®Google Scholar
• Okeke EB, Uzonna JE. The pivotal role of regulatory T cells in the regulation of innate immune cells. Front Immunol. 2019;10:680. doi:10.3389/fimmu.2019.00680.
   PubMed Web of Science ®Google Scholar
• Loevenich K, Ueffing K, Abel S, et al. DC-derived IL-10 modulates pro-inflammatory cytokine production and promotes induction of CD4+ IL-10+ regulatory T cells during Plasmodium yoelii infection. Front Immunol. 2017;8:152. doi:10.3389/fimmu.2017.00152.
   PubMed Web of Science ®Google Scholar
• Raker VK, Domogalla MP, Steinbrink K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front Immunol. 2015;6:569. doi:10.3389/fimmu.2015.00569.
   PubMed Web of Science ®Google Scholar
• Iwata M, Yokota A. Retinoic acid production by intestinal dendritic cells. In: Gerald Litwack, ed., Vitamins & Hormones. Vol. 86. Academic Press London: Elsevier; 2011:127–152.
   Google Scholar
• Balmer JE, Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res. 2002;43(11):1773–1808. doi:10.1194/jlr.R100015-JLR200.
   PubMed Web of Science ®Google Scholar
• Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS. CD4+ CD25+ Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA. 2007;104(49):19446–19451. doi:10.1073/pnas.0706832104.
   PubMed Web of Science ®Google Scholar
• Venet F, Pachot A, Debard A-L, et al. Human CD4+ CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol. 2006;177(9):6540–6547. doi:10.4049/jimmunol.177.9.6540.
   PubMed Web of Science ®Google Scholar
• Okeke EB, Okwor I, Uzonna JE. Regulatory T cells restrain CD4+ T cells from causing unregulated immune activation and hypersensitivity to lipopolysaccharide challenge. J Immunol. 2014;193(2):655–662. doi:10.4049/jimmunol.1303064.
   PubMed Web of Science ®Google Scholar
• Lewkowicz N, Klink M, Mycko MP, Lewkowicz P. Neutrophil–CD4+ CD25+ T regulatory cell interactions: a possible new mechanism of infectious tolerance. Immunobiology. 2013;218(4):455–464. doi:10.1016/j.imbio.2012.05.029.
   PubMed Web of Science ®Google Scholar
• Himmel ME, Crome SQ, Ivison S, Piccirillo C, Steiner TS, Levings MK. Human CD4+ FOXP3+ regulatory T cells produce CXCL8 and recruit neutrophils. Eur J Immunol. 2011;41(2):306–312. doi:10.1002/eji.201040459.
   PubMed Web of Science ®Google Scholar
• Zhu L, Yang P, Zhao Y, et al. Single-cell sequencing of peripheral blood mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients. Immunity. 2020;53(3):685–696.e3.
   PubMed Web of Science ®Google Scholar
• Kuri-Cervantes L, Pampena MB, Meng W, et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol. 2020;5(49):eabd7114. doi:10.1126/sciimmunol.abd7114.
   PubMed Web of Science ®Google Scholar
• Timoteo RP, da Silva MV, Miguel CB, et al. Th1/Th17-related cytokines and chemokines and their implications in the pathogenesis of pemphigus vulgaris. Mediators Inflamm. 2017;2017:7151285–7151285. doi:10.1155/2017/7151285.
   PubMed Web of Science ®Google Scholar
• Harbour SN, DiToro DF, Witte SJ, et al. TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci Immunol. 2020;5(49):eaaw2262. doi:10.1126/sciimmunol.aaw2262.
   PubMed Web of Science ®Google Scholar
• Das A, Xu H, Wang X, Yau CL, Veazey RS, Pahar B. Double-Positive CD21+CD27+ B cells are highly proliferating memory cells and their distribution differs in mucosal and peripheral tissues. PLoS One. 2011;6(1):e16524. doi:10.1371/journal.pone.0016524.
   PubMed Web of Science ®Google Scholar
• Doi H, Tanoue S, Kaplan DE. Peripheral CD27−CD21− B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150(2):184–191. doi:10.1016/j.clim.2013.12.001.
   PubMed Web of Science ®Google Scholar
• Golinski M-L, Demeules M, Derambure C, et al. CD11c+ B cells are mainly memory cells, precursors of antibody secreting cells in healthy donors. Front Immunol. 2020;11:32. doi:10.3389/fimmu.2020.00032.
   PubMed Web of Science ®Google Scholar
• Karnell JL, Kumar V, Wang J, Wang S, Voynova E, Ettinger R. Role of CD11c+ T-bet + B cells in human health and disease. Cell Immunol. 2017;321:40–45. doi:10.1016/j.cellimm.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Nielsen SCA, Yang F, Hoh RA, et al. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Cell Host & Microbe. 2020;28(4): 516–525.e5. doi:10.1016/j.chom.2020.09.002.
   Google Scholar
• Zhang B, Zhou X, Zhu C, et al. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci. 2020;7:157. doi:10.3389/fmolb.2020.00157.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206. doi:10.1186/s12967-020-02374-0.
   PubMed Web of Science ®Google Scholar
• Moderbacher CR, Ramirez SI, Dan JM, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;S0092-8674(20)31235–6. doi:10.1016/j.cell.2020.09.038.
   Web of Science ®Google Scholar
• Araki K, Harada K, Nakamoto K, Shiroma M, Miyakuni T. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers. Clin Exp Immunol. 2000;119(2):259–263. doi:10.1046/j.1365-2249.2000.01136.x.
   PubMed Web of Science ®Google Scholar
• Codo AC, Davanzo GG, Monteiro LdB, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 2020;32:1–10.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shen C, Li J, et al. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 2020;146(1):119–127.e4. doi:10.1016/j.jaci.2020.04.027.
   PubMed Web of Science ®Google Scholar
• Cugno M, Meroni PL, Gualtierotti R, et al. Complement activation in patients with COVID-19: a novel therapeutic target. J Allergy Clin Immunol. 2020;146(1):215–217.
   PubMed Web of Science ®Google Scholar
• Gao T, Hu M, Zhang X, et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. medRxiv 2020.03.29.20041962. 2020.
   Google Scholar
• Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1–13. doi:10.1016/j.trsl.2020.04.007.
   PubMed Web of Science ®Google Scholar
• Ramlall V, Thangaraj PM, Meydan C, et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med. 2020;26(10):1609–1615. doi:10.1038/s41591-020-1021-2.
   PubMed Web of Science ®Google Scholar
• Munthe-Fog L, Hummelshoj T, Honoré C, et al. Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation. Genes Immun. 2012;13(7):515–522. doi:10.1038/gene.2012.27.
   PubMed Web of Science ®Google Scholar
• Elkoumi MA, Abdellatif SH, Mohamed FY, et al. Ficolin-1 gene (FCN1) −144 C/A polymorphism is associated with adverse outcome of severe pneumonia in the under-five Egyptian children: a multicenter study. Pediatr Pulmonol. 2020;55(5):1175–1183. doi:10.1002/ppul.24719.
   PubMed Web of Science ®Google Scholar
• Veras FP, Pontelli MC, Silva CM, et al. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217(12):e20201129. doi:10.1084/jem.20201129.
   PubMed Web of Science ®Google Scholar
• Radermecker C, Detrembleur N, Guiot J, et al. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J Exp Med. 2020;217(12):e20201012. doi:10.1084/jem.20201012.
   PubMed Web of Science ®Google Scholar
• Jones JE, Causey CP, Knuckley B, Slack-Noyes JL, Thompson PR. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr Opin Drug Discov Dev. 2009;12(5):616–627.
   PubMedGoogle Scholar
• Lee W-B, Choi WY, Lee D-H, Shim H, Kim-Ha J, Kim Y-J. OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages. BMB Rep. 2019;52(2):133–138. doi:10.5483/BMBRep.2019.52.2.129.
   PubMed Web of Science ®Google Scholar
• Pichlmair A, Lassnig C, Eberle C-A, et al. IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA. Nat Immunol. 2011;12(7):624–630. doi:10.1038/ni.2048.
   PubMed Web of Science ®Google Scholar
• Naito Y, Takagi T, Higashimura Y. Heme oxygenase-1 and anti-inflammatory M2 macrophages. Arch Biochem Biophys. 2014;564:83–88. doi:10.1016/j.abb.2014.09.005.
   PubMed Web of Science ®Google Scholar
• Vijayan V, Wagener FADTG, Immenschuh S. The macrophage heme-heme oxygenase-1 system and its role in inflammation. Biochem Pharmacol. 2018;153:159–167. doi:10.1016/j.bcp.2018.02.010.
   PubMed Web of Science ®Google Scholar
• Wang T, Liu H, Lian G, Zhang S-Y, Wang X, Jiang C. HIF1α-induced glycolysis metabolism is essential to the activation of inflammatory macrophages. Mediators Inflamm. 2017;2017:9029327. doi:10.1155/2017/9029327.
   PubMed Web of Science ®Google Scholar
• Wang K, Chen W, Zhou Y-S, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. 2020.03.14.988345. 2020.
   Google Scholar
• Stanczak MA, Sanin DE, Apostolova P, et al. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals. medRxiv. 2020.07.09.20148056. 2020.
   Google Scholar
• Wang C, Xie J, Zhao L, et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine. 2020;57:102833. doi:10.1016/j.ebiom.2020.102833.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Ren L, Zhang L, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27(6):883–890.e2. doi:10.1016/j.chom.2020.04.017.
   PubMed Web of Science ®Google Scholar
• Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036–1045.e9. doi:10.1016/j.cell.2020.04.026.
   PubMed Web of Science ®Google Scholar
• Bouhaddou M, Memon D, Meyer B, et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182(3):685–712.e19. doi:10.1016/j.cell.2020.06.034.
   PubMed Web of Science ®Google Scholar
• Pizzorno A, Padey B, Julien T, et al. Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Rep Med. 2020;1(4):100059. doi:10.1016/j.xcrm.2020.100059.
   PubMedGoogle Scholar
• Mai J, Virtue A, Shen J, Wang H, Yang X-F. An evolving new paradigm: endothelial cells–conditional innate immune cells. J Hematol Oncol. 2013;6:61.
   PubMed Web of Science ®Google Scholar
• Shao Y, Saredy J, Yang WY, et al. Vascular endothelial cells and innate immunity. Arterioscler Thromb Vasc Biol. 2020;40(6):e138–e152. doi:10.1161/ATVBAHA.120.314330.
   PubMed Web of Science ®Google Scholar
• Teuwen L-A, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389–391. doi:10.1038/s41577-020-0343-0.
   PubMed Web of Science ®Google Scholar
• Green SJ. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency. Microbes Infect. 2020;22(4-5):149–150. doi:10.1016/j.micinf.2020.05.006.
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5.
   PubMed Web of Science ®Google Scholar
• Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190:62. doi:10.1016/j.thromres.2020.04.014.
   PubMed Web of Science ®Google Scholar
• Nizzoli ME, Merati G, Tenore A, et al. Circulating endothelial cells in COVID-19. Am J Hematol. 2020;95(8):E187–E188. doi:10.1002/ajh.25881.
   PubMed Web of Science ®Google Scholar
• Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182(1):59–72.e15. doi:10.1016/j.cell.2020.05.032.
   PubMed Web of Science ®Google Scholar
• Guillemin GJ, Smith DG, Smythe GA, Armati PJ, Brew BJ. Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol. 2003;527:105–112. doi:10.1007/978-1-4615-0135-0_12.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res. 2009;2:1–19. doi:10.4137/ijtr.s2097.
   PubMed Web of Science ®Google Scholar
• Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol. 2003;81(4):247–265. doi:10.1046/j.1440-1711.2003.t01-1-01177.x.
   PubMed Web of Science ®Google Scholar
• Munn DH, Sharma MD, Baban B, et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 2005;22(5):633–642. doi:10.1016/j.immuni.2005.03.013.
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Tryptophan catabolism and regulation of adaptive immunity. J Immunol. 2003;170(12):5809–5813. doi:10.4049/jimmunol.170.12.5809.
   PubMed Web of Science ®Google Scholar
• Moroni F, Fossati S, Chiarugi A, Cozzi A. Kynurenic acid actions in brain and periphery. Int Congr Ser. 2007;1304:305–313. doi:10.1016/j.ics.2007.07.016.
   Google Scholar
• Sekkaï D, Guittet O, Lemaire G, Tenu JP, Lepoivre M. Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthranilic acid, a tryptophan metabolite. Arch Biochem Biophys. 1997;340(1):117–123. doi:10.1006/abbi.1997.9913.
   PubMed Web of Science ®Google Scholar
• Sorgdrager FJH, Naudé PJW, Kema IP, Nollen EA, Deyn PPD. Tryptophan metabolism in inflammaging: from biomarker to therapeutic target. Front Immunol. 2019;10:2565. doi:10.3389/fimmu.2019.02565.
   PubMed Web of Science ®Google Scholar
• Ravishankar B, Liu H, Shinde R, et al. The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity. Proc Natl Acad Sci USA. 2015;112(34):10774–10779. doi:10.1073/pnas.1504276112.
   PubMed Web of Science ®Google Scholar
• Song JW, Lam SM, Fan X, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020.
   Web of Science ®Google Scholar
• Saba JD, Hla T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res. 2004;94(6):724–734. doi:10.1161/01.RES.0000122383.60368.24.
   PubMed Web of Science ®Google Scholar
• Ito K, Anada Y, Tani M, et al. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem Biophys Res Commun. 2007;357(1):212–217. doi:10.1016/j.bbrc.2007.03.123.
   PubMed Web of Science ®Google Scholar
• Kim RH, Takabe K, Milstien S, Spiegel S. Export and functions of sphingosine-1-phosphate. Biochim Biophys Acta. 2009;1791(7):692–696. doi:10.1016/j.bbalip.2009.02.011.
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Simmons S, Kawamura S, et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest. 2012;122(4):1416–1426. doi:10.1172/JCI60746.
   PubMed Web of Science ®Google Scholar
• Venkataraman K, Lee YM, Michaud J, et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res. 2008;102(6):669–676. doi:10.1161/CIRCRESAHA.107.165845.
   PubMed Web of Science ®Google Scholar
• Nijnik A, Clare S, Hale C, et al. The role of sphingosine-1-phosphate transporter Spns2 in immune system function. J Immunol. 2012;189(1):102–111. doi:10.4049/jimmunol.1200282.
   PubMed Web of Science ®Google Scholar
• Mendoza A, Bréart B, Ramos-Perez WD, et al. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep. 2012;2(5):1104–1110. doi:10.1016/j.celrep.2012.09.021.
   PubMed Web of Science ®Google Scholar
• Liu W, Li H. 2020. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv.
   Google Scholar
• Thomas T, Stefanoni D, Dzieciatkowska M, et al. Evidence for structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. medRxiv. 2020.06.29.20142703. 2020.
   Google Scholar
• Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020;10(2):1271. doi:10.4081/cp.2020.1271.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148. doi:10.1016/j.cca.2020.03.022.
   PubMed Web of Science ®Google Scholar
• Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205–1208. doi:10.1007/s00277-020-04019-0.
   PubMed Web of Science ®Google Scholar
• Rao S, Lau A, So H-C. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Dia Care. 2020;43(7):1416–1426. doi:10.2337/dc20-0643.
   PubMed Web of Science ®Google Scholar
• Bhowmick R, Clark S, Bonventre JV, Leong JM, McCormick BA. Cytosolic phospholipase A(2)α promotes pulmonary inflammation and systemic disease during Streptococcus pneumoniae infection. Infect Immun. 2017;85(11):e00280-17. doi:10.1128/IAI.00280-17.
   PubMed Web of Science ®Google Scholar
• Polonikov A. Endogenous deficiency of glutathione as the most likely cause of serious manifestations and death in COVID-19 patients. ACS Infect Dis. 2020;6(7):1558–1562. doi:10.1021/acsinfecdis.0c00288.
   PubMed Web of Science ®Google Scholar
• Hastie CE, Pell JP, Sattar N. Vitamin D and COVID-19 infection and mortality in UK Biobank. Eur J Nutr. 2020;1–4. doi:10.1007/s00394-020-02372-4.
   Web of Science ®Google Scholar
• Hastie CE, Mackay DF, Ho F, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020;14(4):561–565. doi:10.1016/j.dsx.2020.04.050.
   PubMed Web of Science ®Google Scholar
• Baktash V, Hosack T, Patel N, et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. 2020;138712. doi:10.1136/postgradmedj-2020-138712.
   Google Scholar
• Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open. 2020;3(9):e2019722. doi:10.1001/jamanetworkopen.2020.19722.
   PubMed Web of Science ®Google Scholar
• Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881–886. doi:10.2310/JIM.0b013e31821b8755.
   PubMed Web of Science ®Google Scholar
• Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol. 2020;8(7):570. doi:10.1016/S2213-8587(20)30183-2.
   PubMed Web of Science ®Google Scholar
• Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine. 2009;45(3):190–197. doi:10.1016/j.cyto.2008.12.009.
   PubMed Web of Science ®Google Scholar
• Dimitrov V, White JH. Species-specific regulation of innate immunity by vitamin D signaling. J Steroid Biochem Mol Biol. 2016;164:246–253. doi:10.1016/j.jsbmb.2015.09.016.
   PubMed Web of Science ®Google Scholar
• Muñoz Garcia A, Kutmon M, Eijssen L, Hewison M, Evelo CT, Coort SL. Pathway analysis of transcriptomic data shows immunometabolic effects of vitamin D. J Mol Endocrinol. 2018;60(2):95–108. doi:10.1530/JME-17-0186.
   PubMed Web of Science ®Google Scholar
• Kumar V. Immunometabolism: another road to sepsis and its therapeutic targeting. Inflammation. 2019;42(3):765–788. doi:10.1007/s10753-018-0939-8.
   PubMed Web of Science ®Google Scholar
• Kumar V. Targeting macrophage immunometabolism: dawn in the darkness of sepsis. Int Immunopharmacol. 2018;58:173–185. doi:10.1016/j.intimp.2018.03.005.
   PubMed Web of Science ®Google Scholar
• Kumar V. Natural killer cells in sepsis: underprivileged innate immune cells. Eur J Cell Biol. 2019;98(2-4):81–93. doi:10.1016/j.ejcb.2018.12.003.
   PubMed Web of Science ®Google Scholar
• Kumar V. T cells and their immunometabolism: a novel way to understanding sepsis immunopathogenesis and future therapeutics. Eur J Cell Biol. 2018;97(6):379–392. doi:10.1016/j.ejcb.2018.05.001.
   PubMed Web of Science ®Google Scholar
• Kumar V. Dendritic cells in sepsis: potential immunoregulatory cells with therapeutic potential. Mol Immunol. 2018;101:615–626. doi:10.1016/j.molimm.2018.07.007.
   PubMed Web of Science ®Google Scholar
• Gardinassi LG, Souza COS, Sales-Campos H, Fonseca SG. Immune and metabolic signatures of COVID-19 revealed by transcriptomics data reuse. Front Immunol. 2020;11:1636. doi:10.3389/fimmu.2020.01636.
   PubMed Web of Science ®Google Scholar
• Zhao R-Z, Jiang S, Zhang L, Yu Z-B. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med. 2019;44(1):3–15. doi:10.3892/ijmm.2019.4188.
   PubMed Web of Science ®Google Scholar
• Ma J, Wei K, Liu J, et al. Glycogen metabolism regulates macrophage-mediated acute inflammatory responses. Nat Commun. 2020;11(1):1769. doi:10.1038/s41467-020-15636-8.
   PubMed Web of Science ®Google Scholar
• Semba H, Takeda N, Isagawa T, et al. HIF-1α-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity. Nat Commun. 2016;7:11635. doi:10.1038/ncomms11635.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Prados JC, Través PG, Cuenca J, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol. 2010;185(1):605–614. doi:10.4049/jimmunol.0901698.
   PubMed Web of Science ®Google Scholar
• Roche TE, Baker JC, Yan X, et al. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. In Progress in Nucleic Acid Research and Molecular Biology. Vol. 70. Academic Press; 2001:33–75.
   Google Scholar
• Shalova IN, Lim JY, Chittezhath M, et al. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α. Immunity. 2015;42(3):484–498. doi:10.1016/j.immuni.2015.02.001.
   PubMed Web of Science ®Google Scholar
• Ryan DG, O’Neill LAJ. Krebs cycle reborn in macrophage immunometabolism. Annu Rev Immunol. 2020;38:289–313. doi:10.1146/annurev-immunol-081619-104850.
   PubMed Web of Science ®Google Scholar
• Seim GL, Britt EC, John SV, et al. Two-stage metabolic remodelling in macrophages in response to lipopolysaccharide and interferon-γ stimulation. Nat Metab. 2019;1(7):731–742. doi:10.1038/s42255-019-0083-2.
   PubMedGoogle Scholar
• Tannahill G, Curtis A, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496(7444):238–242. doi:10.1038/nature11986.
   PubMed Web of Science ®Google Scholar
• Cordes T, Wallace M, Michelucci A, et al. Immunoresponsive Gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J Biol Chem. 2016;291(27):14274–14284. doi:10.1074/jbc.M115.685792.
   PubMed Web of Science ®Google Scholar
• Lampropoulou V, Sergushichev A, Bambouskova M, et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 2016;24(1):158–166. doi:10.1016/j.cmet.2016.06.004.
   PubMed Web of Science ®Google Scholar
• Kobayashi EH, Suzuki T, Funayama R, et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun. 2016;7(1):1–14. doi:10.1038/ncomms11624.
   Google Scholar
• Mills EL, Ryan DG, Prag HA, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556(7699):113–117. doi:10.1038/nature25986.
   PubMed Web of Science ®Google Scholar
• Hooftman A, Angiari S, Hester S, et al. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 2020;32(3):468–478.e7.
   PubMed Web of Science ®Google Scholar
• He Y, Zeng MY, Yang D, Motro B, Núñez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530(7590):354–357. doi:10.1038/nature16959.
   PubMed Web of Science ®Google Scholar
• Schmacke NA, Gaidt MM, Szymanska I, et al. Priming enables a NEK7-independent route of NLRP3 activation. bioRxiv. 10.1101/799320. 2019.
   Google Scholar
• Yan B, Chu H, Yang D, et al. Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication. Viruses. 2019;11(1):73. doi:10.3390/v11010073.
   PubMed Web of Science ®Google Scholar
• Yuan S, Chu H, Chan JF, et al. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat Commun. 2019;10(1):120. doi:10.1038/s41467-018-08015-x.
   PubMed Web of Science ®Google Scholar
• Wolff G, Melia CE, Snijder EJ, Bárcena M. Double-membrane vesicles as platforms for viral replication. Trends Microbiol. 2020.
   PubMed Web of Science ®Google Scholar
• Colgan SP, Curtis VF, Lanis JM, Glover LE. Metabolic regulation of intestinal epithelial barrier during inflammation. Tissue Barriers. 2015;3(1-2):e970936. doi:10.4161/21688362.2014.970936.
   PubMed Web of Science ®Google Scholar
• Smallwood HS, Duan S, Morfouace M, et al. Targeting metabolic reprogramming by influenza infection for therapeutic intervention. Cell Rep. 2017;19(8):1640–1653. doi:10.1016/j.celrep.2017.04.039.
   PubMed Web of Science ®Google Scholar
• Bojkova D, Klann K, Koch B, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583(7816):469–472. doi:10.1038/s41586-020-2332-7.
   PubMed Web of Science ®Google Scholar
• Goetzman ES, Prochownik EV. The role for Myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues. Front Endocrinol. 2018;9:129. doi:10.3389/fendo.2018.00129.
   PubMed Web of Science ®Google Scholar
• Rehwinkel J, Gack MU. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol. 2020;20(9):537–551. doi:10.1038/s41577-020-0288-3.
   PubMed Web of Science ®Google Scholar
• Gordon DE, Jang GM, Bouhaddou M, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459–468. doi:10.1038/s41586-020-2286-9.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang G, Xu Z-G, et al. Lactate is a natural suppressor of RLR signaling by targeting MAVS. Cell. 2019;178(1):176–189.e15. doi:10.1016/j.cell.2019.05.003.
   PubMed Web of Science ®Google Scholar
• Hou F, Sun L, Zheng H, Skaug B, Jiang Q-X, Chen ZJ. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell. 2011;146(3):448–461. doi:10.1016/j.cell.2011.06.041.
   PubMed Web of Science ®Google Scholar
• Lio C-WJ, McDonald B, Takahashi M, et al. cGAS-STING signaling regulates initial innate control of cytomegalovirus infection. J Virol. 2016;90(17):7789–7797. doi:10.1128/JVI.01040-16.
   PubMed Web of Science ®Google Scholar
• Demaria O, De Gassart A, Coso S, et al. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proc Natl Acad Sci USA. 2015;112(50):15408–15413. doi:10.1073/pnas.1512832112.
   PubMed Web of Science ®Google Scholar
• Khakpour S, Wilhelmsen K, Hellman J. Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate Immun. 2015;21(8):827–846. doi:10.1177/1753425915606525.
   PubMed Web of Science ®Google Scholar
• Zanone MM, Favaro E, Ferioli E, et al. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection. FASEB J. 2007;21(12):3308–3317. doi:10.1096/fj.06-7905com.
   PubMed Web of Science ®Google Scholar
• Hardy M-P, Audemard É, Migneault F, et al. Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs. Sci Rep. 2019;9(1):7203. doi:10.1038/s41598-019-43591-y.
   PubMedGoogle Scholar
• Eelen G, de Zeeuw P, Simons M, Carmeliet P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 2015;116(7):1231–1244. doi:10.1161/CIRCRESAHA.116.302855.
   PubMed Web of Science ®Google Scholar
• Wong BW, Marsch E, Treps L, Baes M, Carmeliet P. Endothelial cell metabolism in health and disease: impact of hypoxia. EMBO J. 2017;36(15):2187–2203. doi:10.15252/embj.201696150.
   PubMed Web of Science ®Google Scholar
• O’Neill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213(1):15–23. doi:10.1084/jem.20151570.
   PubMed Web of Science ®Google Scholar
• Pearce EJ, Everts B. Dendritic cell metabolism. Nat Rev Immunol. 2015;15(1):18–29. doi:10.1038/nri3771.
   PubMed Web of Science ®Google Scholar
• Law HKW, Cheung CY, Ng HY, et al. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood. 2005;106(7):2366–2374. doi:10.1182/blood-2004-10-4166.
   PubMed Web of Science ®Google Scholar
• Yang D, Chu H, Hou Y, et al. Attenuated interferon and proinflammatory response in SARS-CoV-2–infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. J Infect Dis. 2020;222(5):734–745. doi:10.1093/infdis/jiaa356.
   PubMed Web of Science ®Google Scholar
• Krawczyk CM, Holowka T, Sun J, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115(23):4742–4749. doi:10.1182/blood-2009-10-249540.
   PubMed Web of Science ®Google Scholar
• Thwe PM, Pelgrom LR, Cooper R, et al. Cell-intrinsic glycogen metabolism supports early glycolytic reprogramming required for dendritic cell immune responses. Cell Metab. 2017;26(3):558–567.e5. doi:10.1016/j.cmet.2017.08.012.
   PubMed Web of Science ®Google Scholar
• Curtis KD, Smith PR, Despres HW, et al. Glycogen metabolism supports early glycolytic reprogramming and activation in dendritic cells in response to both TLR and Syk-dependent CLR agonists. Cells. 2020;9(3):715. doi:10.3390/cells9030715.
   Web of Science ®Google Scholar
• Everts B, Amiel E, Huang SC, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nat Immunol. 2014;15(4):323–332. doi:10.1038/ni.2833.
   PubMed Web of Science ®Google Scholar
• Spirig R, Djafarzadeh S, Regueira T, et al. Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1α and dendritic cell maturation under normoxic conditions. PLoS One. 2010;5(6):e10983. doi:10.1371/journal.pone.0010983.
   Web of Science ®Google Scholar
• Arunachalam PS, Wimmers F, Mok CKP, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369(6508):1210–1220. doi:10.1126/science.abc6261.
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Murphy AN, Brown JH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 2008;15(3):521–529. doi:10.1038/sj.cdd.4402285.
   PubMed Web of Science ®Google Scholar
• Jin X, Zhang W, Wang Y, et al. Pyruvate kinase M2 promotes the activation of dendritic cells by enhancing IL-12p35 expression. Cell Rep. 2020;31(8):107690. doi:10.1016/j.celrep.2020.107690.
   PubMed Web of Science ®Google Scholar
• Wu D, Sanin DE, Everts B, et al. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity. 2016;44(6):1325–1336. doi:10.1016/j.immuni.2016.06.006.
   PubMed Web of Science ®Google Scholar
• DeWaal D, Nogueira V, Terry AR, et al. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun. 2018;9(1):446. doi:10.1038/s41467-017-02733-4.
   PubMed Web of Science ®Google Scholar
• Lau YL, Peiris JS, Law HK. Role of dendritic cells in SARS coronavirus infection. Hong Kong Med J. 2012;18(Suppl 3):28–30.
   PubMedGoogle Scholar
• Falschlehner C, Schaefer U, Walczak H. Following TRAIL’s path in the immune system. Immunology. 2009;127(2):145–154. doi:10.1111/j.1365-2567.2009.03058.x.
   PubMed Web of Science ®Google Scholar
• Ciscato F, Filadi R, Masgras I, et al. Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca2+ -dependent death of cancer cells . EMBO Rep. 2020;21(7):e49117. doi:10.15252/embr.201949117.
   PubMed Web of Science ®Google Scholar
• Nicolai CJ, Wolf N, Chang I-C, et al. NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists. Sci Immunol. 2020;5(45):eaaz2738. doi:10.1126/sciimmunol.aaz2738.
   PubMed Web of Science ®Google Scholar
• Masselli E, Vaccarezza M, Carubbi C, et al. NK cells: A double edge sword against SARS-CoV-2. Adv Biol Regul. 2020;77:100737. doi:10.1016/j.jbior.2020.100737.
   PubMedGoogle Scholar
• Antonioli L, Fornai M, Pellegrini C, Blandizzi C. NKG2A and COVID-19: another brick in the wall. Cell Mol Immunol. 2020;17(6):672–674. doi:10.1038/s41423-020-0450-7.
   PubMed Web of Science ®Google Scholar
• Wu J, Gao F-x, Wang C, et al. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2019;38(1):321. doi:10.1186/s13046-019-1310-0.
   PubMedGoogle Scholar
• Geng J-J, Tang J, Yang X-M, et al. Targeting CD147 for T to NK lineage reprogramming and tumor therapy. EBioMedicine. 2017;20:98–108. doi:10.1016/j.ebiom.2017.05.022.
   PubMed Web of Science ®Google Scholar
• Jurewicz M, McDermott DH, Sechler JM, et al. Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II–induced inflammation. JASN. 2007;18(4):1093–1102. doi:10.1681/ASN.2006070707.
   Web of Science ®Google Scholar
• Michelet X, Dyck L, Hogan A, et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat Immunol. 2018;19(12):1330–1340. doi:10.1038/s41590-018-0251-7.
   PubMed Web of Science ®Google Scholar
• Tobin LM, Mavinkurve M, Carolan E, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2017;2(24):e94939. doi:10.1172/jci.insight.94939.
   PubMed Web of Science ®Google Scholar
• Lynch LA, O’Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O’Shea DB. Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring). 2009;17(3):601–605. doi:10.1038/oby.2008.565.
   PubMed Web of Science ®Google Scholar
• O’Shea D, Cawood TJ, O'Farrelly C, Lynch L. Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS One. 2010;5(1):e8660. doi:10.1371/journal.pone.0008660.
   PubMed Web of Science ®Google Scholar
• Keppel MP, Saucier N, Mah AY, Vogel TP, Cooper MA. Activation-specific metabolic requirements for NK Cell IFN-γ production. J Immunol. 2015;194(4):1954–1962. doi:10.4049/jimmunol.1402099.
   PubMed Web of Science ®Google Scholar
• Marçais A, Cherfils-Vicini J, Viant C, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol. 2014;15(8):749–757. doi:10.1038/ni.2936.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Finlay DK. Immunometabolism and natural killer cell responses. Nat Rev Immunol. 2019;19(5):282–290. doi:10.1038/s41577-019-0139-2.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Mattarollo SR. Natural killer cell metabolism. Mol Immunol. 2019;115:3–11. doi:10.1016/j.molimm.2017.11.021.
   PubMed Web of Science ®Google Scholar
• Gardiner CM. NK cell metabolism. J Leukoc Biol. 2019;105(6):1235–1242. doi:10.1002/JLB.MR0718-260R.
   PubMed Web of Science ®Google Scholar
• Donnelly RP, Loftus RM, Keating SE, et al. mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J Immunol. 2014;193(9):4477–4484. doi:10.4049/jimmunol.1401558.
   PubMed Web of Science ®Google Scholar
• Assmann N, O’Brien KL, Donnelly RP, et al. Srebp-controlled glucose metabolism is essential for NK cell functional responses. Nat Immunol. 2017;18(11):1197–1206. doi:10.1038/ni.3838.
   PubMed Web of Science ®Google Scholar
• Mah AY, Rashidi A, Keppel MP, et al. Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control. JCI Insight. 2017;2(23):e95128. doi:10.1172/jci.insight.95128.
   PubMed Web of Science ®Google Scholar
• Loftus RM, Assmann N, Kedia-Mehta N, et al. Amino acid-dependent c-Myc expression is essential for NK cell metabolic and functional responses in mice. Nat Commun. 2018;9(1):2341. doi:10.1038/s41467-018-04719-2.
   PubMedGoogle Scholar
• Li M-Y, Li L, Zhang Y, Wang X-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. doi:10.1186/s40249-020-00662-x.
   PubMed Web of Science ®Google Scholar
• Biegler B, Kasinrerk W. Reduction of CD147 surface expression on primary T cells leads to enhanced cell proliferation. Asian Pac J Allergy Immunol. 2012;30(4):259–267.
   PubMed Web of Science ®Google Scholar
• Landskron J, Taskén K. CD147 in regulatory T cells. Cell Immunol. 2013;282(1):17–20. doi:10.1016/j.cellimm.2013.04.008.
   PubMed Web of Science ®Google Scholar
• Solstad T, Bains SJ, Landskron J, et al. CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells. Blood. 2011;118(19):5141–5151. doi:10.1182/blood-2011-02-339242.
   PubMed Web of Science ®Google Scholar
• Guo N, Ye S, Zhang K, et al. A critical epitope in CD147 facilitates memory CD4+ T-cell hyper-activation in rheumatoid arthritis. Cell Mol Immunol. 2019;16(6):568–579. doi:10.1038/s41423-018-0012-4.
   PubMed Web of Science ®Google Scholar
• Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med. 1999;189(3):521–530. doi:10.1084/jem.189.3.521.
   PubMed Web of Science ®Google Scholar
• Mansson A, Adner M, Cardell LO. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res. 2006;7:36. doi:10.1186/1465-9921-7-36.
   PubMed Web of Science ®Google Scholar
• Li W, Lu L, Lu J, et al. cGAS-STING–mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy. Sci Transl Med. 2020;12(549):eaay9013. doi:10.1126/scitranslmed.aay9013.
   PubMed Web of Science ®Google Scholar
• Aguilar-Valenzuela RA, Ma DY, Suthar MS. The role of the RIG-I like receptors in mediating CD8+ T cell immunity during virus infection. J Immunol. 2016;196:148.6.
   Web of Science ®Google Scholar
• Vanderheiden A, Aguilar-Valenzuela R, Verkerke H, et al. CD8+ T cell intrinsic MAVS promotes antigen-specific responses and mitochondrial metabolism during West Nile Virus neuroinvasive disease. J Immunol. 2020;204:94.1.
   Web of Science ®Google Scholar
• Suthar MS, Ramos HJ, Brassil MM, et al. The RIG-I-like receptor LGP2 controls CD8+ T cell survival and fitness. Immunity. 2012;37(2):235–248. doi:10.1016/j.immuni.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Lazear HM, Pinto AK, Ramos HJ, et al. Pattern recognition receptor MDA5 modulates CD8+ T cell-dependent clearance of West Nile virus from the central nervous system. J Virol. 2013;87(21):11401–11415. doi:10.1128/JVI.01403-13.
   PubMed Web of Science ®Google Scholar
• Schenten D, O’Ketch M. Rig-I-like receptors (RLRs) regulate humoral immunity to West Nile Virus (WNV) infection. J Immunol. 2018;200:126.15.
   Web of Science ®Google Scholar
• Geltink RIK, Kyle RL, Pearce EL. Unraveling the complex interplay between T cell metabolism and function. Annu Rev Immunol. 2018;36:461–488. doi:10.1146/annurev-immunol-042617-053019.
   PubMed Web of Science ®Google Scholar
• Milam AAV, Bartleson JM, Buck MD, et al. Tonic TCR signaling inversely regulates the basal metabolism of CD4+ T cells. Immunohorizons. 2020;4(8):485–497. doi:10.4049/immunohorizons.2000055.
   PubMedGoogle Scholar
• Franchina DG, Dostert C, Brenner D. Reactive oxygen species: involvement in T cell signaling and metabolism. Trends Immunol. 2018;39(6):489–502. doi:10.1016/j.it.2018.01.005.
   PubMed Web of Science ®Google Scholar
• Mak TW, Grusdat M, Duncan GS, et al. Glutathione primes T cell metabolism for inflammation. Immunity. 2017;46(4):675–689. doi:10.1016/j.immuni.2017.03.019.
   PubMed Web of Science ®Google Scholar
• Lian G, Gnanaprakasam JR, Wang T, et al. Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation. Elife. 2018;7:e36158. doi:10.7554/eLife.36158.
   PubMed Web of Science ®Google Scholar
• Wang R, Dillon CP, Shi LZ, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011;35(6):871–882. doi:10.1016/j.immuni.2011.09.021.
   PubMed Web of Science ®Google Scholar
• Diotallevi M, Checconi P, Palamara AT, et al. Glutathione fine-tunes the innate immune response toward antiviral pathways in a macrophage cell line independently of its antioxidant properties. Front Immunol. 2017;8:1239. doi:10.3389/fimmu.2017.01239.
   PubMed Web of Science ®Google Scholar
• Toriyama K, Kuwahara M, Kondoh H, et al. T cell-specific deletion of Pgam1 reveals a critical role for glycolysis in T cell responses. Commun Biol. 2020;3(1):394. doi:10.1038/s42003-020-01122-w.
   PubMed Web of Science ®Google Scholar
• Mendoza A, Fang V, Chen C, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546(7656):158–161. doi:10.1038/nature22352.
   PubMed Web of Science ®Google Scholar
• Pollizzi KN, Patel CH, Sun IH, et al. mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation. J Clin Invest. 2015;125(5):2090–2108. doi:10.1172/JCI77746.
   PubMed Web of Science ®Google Scholar
• Morris SR, Chen B, Mudd JC, et al. Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15. JCI Insight. 2020;5:e132963. doi:10.1172/jci.insight.132963.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Walsh MC, Cejas PJ, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009;460(7251):103–107. doi:10.1038/nature08097.
   PubMed Web of Science ®Google Scholar
• Hedrick SM, Hess Michelini R, Doedens AL, Goldrath AW, Stone EL. FOXO transcription factors throughout T cell biology. Nat Rev Immunol. 2012;12(9):649–661. doi:10.1038/nri3278.
   PubMed Web of Science ®Google Scholar
• Hess Michelini R, Doedens AL, Goldrath AW, Hedrick SM. Differentiation of CD8 memory T cells depends on Foxo1. J Exp Med. 2013;210(6):1189–1200. doi:10.1084/jem.20130392.
   PubMed Web of Science ®Google Scholar
• van der Windt GJ, Everts B, Chang CH, et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity. 2012;36(1):68–78. doi:10.1016/j.immuni.2011.12.007.
   PubMed Web of Science ®Google Scholar
• Dorner M, Brandt S, Tinguely M, et al. Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunology. 2009;128(4):573–579. doi:10.1111/j.1365-2567.2009.03143.x.
   PubMed Web of Science ®Google Scholar
• Gram AM, Sun C, Landman SL, et al. Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure. Mol Immunol. 2017;91:225–237. doi:10.1016/j.molimm.2017.08.025.
   PubMed Web of Science ®Google Scholar
• Walker MM, Crute BW, Cambier JC, Getahun A. B cell-intrinsic STING signaling triggers cell activation, synergizes with B cell receptor signals, and promotes antibody responses. J Immunol. 2018;201(9):2641–2653. doi:10.4049/jimmunol.1701405.
   PubMed Web of Science ®Google Scholar
• Koch C, Staffler G, Hüttinger R, et al. T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density. Int Immunol. 1999;11(5):777–786. doi:10.1093/intimm/11.5.777.
   PubMed Web of Science ®Google Scholar
• Melchers F. Checkpoints that control B cell development. J Clin Invest. 2015;125(6):2203–2210. doi:10.1172/JCI78083.
   PubMed Web of Science ®Google Scholar
• Corcoran LM, Tarlinton DM. Regulation of germinal center responses, memory B cells and plasma cell formation-an update. Curr Opin Immunol. 2016;39:59–67. doi:10.1016/j.coi.2015.12.008.
   PubMed Web of Science ®Google Scholar
• Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol. 2012;30:429–457. doi:10.1146/annurev-immunol-020711-075032.
   PubMed Web of Science ®Google Scholar
• Aronov M, Tirosh B. Metabolic control of plasma cell differentiation—what we know and what we don’t know. J Clin Immunol. 2016;36(S1):12–17. doi:10.1007/s10875-016-0246-9.
   PubMedGoogle Scholar
• Waters LR, Ahsan FM, Wolf DM, Shirihai O, Teitell MA. Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling. iScience. 2018;5:99–109. doi:10.1016/j.isci.2018.07.005.
   PubMed Web of Science ®Google Scholar
• Wilson CS, Moore DJ. B cell metabolism: an understudied opportunity to improve immune therapy in autoimmune type 1 diabetes. Immunometabolism. 2020;2:e200016.
   Google Scholar
• Caro-Maldonado A, Wang R, Nichols AG, et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J Immunol. 2014;192(8):3626. doi:10.4049/jimmunol.1302062.
   PubMed Web of Science ®Google Scholar
• Cantor J, Browne CD, Ruppert R, et al. CD98hc facilitates B cell proliferation and adaptive humoral immunity. Nat Immunol. 2009;10(4):412–419. doi:10.1038/ni.1712.
   PubMed Web of Science ®Google Scholar
• Boothby M, Rickert RC. Metabolic regulation of the immune humoral response. Immunity. 2017;46(5):743–755. doi:10.1016/j.immuni.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Berry CT, Liu X, Myles A, et al. BCR-induced Ca(2+) signals dynamically tune survival, metabolic reprogramming, and proliferation of naive B cells. Cell Rep. 2020;31(2):107474. doi:10.1016/j.celrep.2020.03.038.
   PubMed Web of Science ®Google Scholar
• Vijay R, Guthmiller JJ, Sturtz AJ, et al. Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria. Nat Immunol. 2020;21(7):790–801. doi:10.1038/s41590-020-0678-5.
   PubMed Web of Science ®Google Scholar
• Meng Q, Guo P, Jiang Z, Bo L, Bian J. Dexmedetomidine inhibits LPS-induced proinflammatory responses via suppressing HIF1α-dependent glycolysis in macrophages. Aging. 2020;12(10):9534–9548. doi:10.18632/aging.103226.
   PubMedGoogle Scholar
• Cui H, Banerjee S, Guo S, Xie N, Liu G. IFN regulatory factor 2 inhibits expression of glycolytic genes and lipopolysaccharide-induced proinflammatory responses in macrophages. J Immunol. 2018;200(9):3218–3230. doi:10.4049/jimmunol.1701571.
   PubMed Web of Science ®Google Scholar
• Vigeland CL, Beggs HS, Collins SL, et al. Inhibition of glutamine metabolism accelerates resolution of acute lung injury. Physiol Rep. 2019;7(5):e14019. doi:10.14814/phy2.14019.
   PubMed Web of Science ®Google Scholar
• Kuo PC, Weng WT, Scofield BA, et al. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2020;17(1):138. doi:10.1186/s12974-020-01768-7.
   PubMed Web of Science ®Google Scholar
• Cirovic B, de Bree LCJ, Groh L, et al. BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment. Cell Host Microbe. 2020;28(2):322–334.e5. doi:10.1016/j.chom.2020.05.014.
   PubMed Web of Science ®Google Scholar
• Arts RJW, Moorlag S, Novakovic B, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23(1):89–100.e5. doi:10.1016/j.chom.2017.12.010.
   PubMed Web of Science ®Google Scholar
• Arts RJW, Joosten LAB, Netea MG. Immunometabolic circuits in trained immunity. Semin Immunol. 2016;28(5):425–430. doi:10.1016/j.smim.2016.09.002.
   PubMed Web of Science ®Google Scholar
• Arts RJW, Novakovic B, ter Horst R, et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 2016;24(6):807–819. doi:10.1016/j.cmet.2016.10.008.
   PubMed Web of Science ®Google Scholar
• Arts RJW, Carvalho A, La Rocca C, et al. Immunometabolic pathways in BCG-induced trained immunity. Cell Rep. 2016;17(10):2562–2571. doi:10.1016/j.celrep.2016.11.011.
   PubMed Web of Science ®Google Scholar
• Kleinnijenhuis J, Quintin J, Preijers F, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun. 2014;6(2):152–158. doi:10.1159/000355628.
   PubMed Web of Science ®Google Scholar
• Netea MG, Giamarellos-Bourboulis EJ, Domínguez-Andrés J, et al. Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell. 2020;181(5):969–977. doi:10.1016/j.cell.2020.04.042.
   PubMed Web of Science ®Google Scholar
• Cheng S-C, Quintin J, Cramer RA, et al. mTOR-and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345(6204):1250684. doi:10.1126/science.1250684.
   PubMed Web of Science ®Google Scholar
• Moorlag SJCFM, van Deuren RC, van Werkhoven CH, et al. Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study. Cell Rep Med. 2020;1(5):100073.
   PubMedGoogle Scholar
• de Bree LCJ, Mourits VP, Koeken VA, et al. Circadian rhythm influences induction of trained immunity by BCG vaccination. J Clin Invest. 2020;130(10):5603–5617. doi:10.1172/JCI133934.
   Web of Science ®Google Scholar
• Koeken VACM, de Bree LCJ, Mourits VP, et al. BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner. J Clin Invest. 2020;130(10):5591–5602. doi:10.1172/JCI133935.
   Web of Science ®Google Scholar
• Braun J, Loyal L, Frentsch M, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020. doi:10.1038/s41586-020-2598-9.
   Web of Science ®Google Scholar